Perfluorocarbon priming and surfactant: Physiologic and pathologic effects

Critical Care Medicine

Volumn 27, Issue 9, 1999, Pages 1916-1922

  Mrozek, Jeanne D ^a,b   Smith, Kendra M ^a,b   Simonton, Susan C ^a   Bing, Dennis R ^a   Meyers, Pat A ^a   Connett, John E ^c   Mammel, Mark C ^a,b,d  

^a Infant Pulmonary Research Center   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

Author keywords

Artificial; Fluorocarbons; Lung compliance; Lung injury; Mechanical; Pulmonary gas exchange; Pulmonary surfactants; Respiration; Respiration mechanics; Ventilation; Ventilators

Indexed keywords

FLUOROCARBON; LUNG SURFACTANT; PERFLUOROOCTYL BROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BREATHING MECHANICS; CONTROLLED STUDY; FUNCTIONAL RESIDUAL CAPACITY; LUNG ALVEOLUS SURFACE TENSION; LUNG COMPLIANCE; LUNG GAS EXCHANGE; LUNG INJURY; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; ANIMALS, NEWBORN; BRONCHOALVEOLAR LAVAGE; EMULSIONS; FLUOROCARBONS; HEMODYNAMIC PROCESSES; HUMANS; INFANT, NEWBORN; LUNG; LUNG COMPLIANCE; PREMEDICATION; PROSPECTIVE STUDIES; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANTS; RANDOM ALLOCATION; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY MECHANICS; SWINE;

EID: 0032883997     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199909000-00033     Document Type: Article

References (21)

1. 1. deRegnier R-A, Roberts D, Ramsey D, et al: Association between the severity of chronic lung disease and first-year outcomes of very low birth weight infants. J Perinatol 1997; 17:375-382
2. 2. Ferrara TB, Hoekstra RE, Couser RJ, et al: Survival and follow-up of infants born at 23 to 26 weeks of gestational age: Effects of surfactant therapy. J Pediatr 1994; 124:119-124
3. 3. Gerdes J, Gerdes M, Beaumont E, et al for the American Exosurf Neonatal Study Groups 1 and 2: Health and neurodevelopmental outcome at 1-year adjusted age in 508 infants weighing 700 to 1100 grams who received prophylaxis with one versus three doses of synthetic surfactant. J Pediatr 1995; 126: S26-S32
4. 4. Sell M, Cotton RB, Hirata T, et al for the American Exosurf Neonatal Study Group 1: One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. J Pediatr 1995; 126:S20-S25
5. 5. Fuhrman BP, Paczan P, DeFrancisis M: Perfluorocarbon associated gas exchange. Crit Care Med 1991; 19:712-722
6. 6. Leach CL, Fuhrman BP, Morin FC III, et al: Perfluorocarbon-associated gas exchange (partial liquid ventilation) in respiratory distress syndrome: A prospective, randomized, controlled study. Crit Care Med 1993; 21: 1270-1278
7. 7. Tütüncü AS, Faithfull NS, Lachmann B: Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: Dose-dependent improvement of gas exchange. Crit Care Med 1993; 21:962-969
8. 8. Houmes RJM, Verbrugge SJC, Hendrik ER, et al: Hemodynamic effects of partial liquid ventilation with perfluorocarbon in acute lung injury. Intensive Care Med 1995; 21: 966-972
9. 9. Leach CL, Greenspan JS, Rubenstein SD, et al for the Liquivent Study Group: Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N Engl J Med 1996; 335:761-767
10. 10. Mrozek JD, Smith KM, Bing DR, et al: Exogenous surfactant and partial liquid ventilation: Physiologic and pathologic effects. Am J Respir Crit Care Med 1997; 156:1058-1065
11. 11. Leach CL, Holm B, Morin FC, et al: Partial liquid ventilation in premature lambs with respiratory distress syndrome: Efficacy and compatibility with exogenous surfactant. J Pediatr 1995; 126:412-420
12. 12. Zobel G, Urlesberger B, Dacar D, et al: Partial liquid ventilation combined with inhaled nitric oxide in acute respiratory failure with pulmonary hypertension in piglets. Pediatr Res 1997; 41:172-177
13. 13. Houmes RJ, Hartog A, Verbrugge SJ, et al: Combining partial liquid ventilation with nitric oxide to improve gas exchange in acute lung injury. Intensive Care Med 1997; 23: 163-169
14. 14. Wolfson MR, Greenspan JS, Shaffer TH: Pulmonary administration of vasoactive substance by perfluorochemical ventilation. Pediatrics 1996; 97:449-455
15. 15. Richman PS, Wolfson MR, Shaffer TH: Lung lavage with oxygenated perfluorochemical in acute lung injury. Crit Care Med 1993; 21: 768-774
16. 16. Lachmann B, Robertson B, Vogel J: In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesth Scand 1980; 24:231-236
17. 17. Wolfson MR, Greenspan JS, Deoras KS: Comparison of gas and liquid ventilation: Clinical, physiological and histological correlates. J Appl Physiol 1992; 72:1024-1032
18. 18. Cotton RB, Olsson T, Law AB, et al: The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease. Pediatr Res 1993; 34:495-501
19. 19. Goldsmith LS, Greenspan JS, Rubenstein SD, et al: Immediate improvement in lung volume after exogenous surfactant: Alveolar recruitment versus increased distention. J Pediatr 1991; 119:424-428
20. 20. Kylstra JA, Shoenfisch WH: Alveolar surface tension in fluorocarbon-filled lungs. J Appl Physiol 1972; 33:32-35
21. 21. Soll RF, McQueen MC: Respiratory distress syndrome. In: Effective Care of the Newborn Infant. Sinclair JC, Bracken MB (Eds). Oxford, UK, Oxford University Press, 1992, pp 329-349